Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy

For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus o...

Full description

Saved in:
Bibliographic Details
Published inCurrent urology reports Vol. 16; no. 11; p. 75
Main Authors Feuerstein, Michael A., Goenka, Anuj
Format Journal Article
LanguageEnglish
Published New York Springer US 01.11.2015
Subjects
Online AccessGet full text
ISSN1527-2737
1534-6285
1534-6285
DOI10.1007/s11934-015-0547-1

Cover

Abstract For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus on patients eligible for radical cystectomy, for whom a comparison of patient-reported outcomes is most relevant. Peer-reviewed, English-language manuscripts in MEDLINE and PubMed databases were examined from 1996 through 2014. Subject headings included quality of life, bladder cancer, bladder sparing, bladder preservation, radiation, and radiotherapy. Prospective and retrospective studies of patient-reported outcomes in patients undergoing bladder preservation with radiotherapy for muscle-invasive bladder cancer were included. Two prospective studies and four retrospective studies were identified. Several weaknesses from these studies were identified including small sample sizes, variable time points of assessment, variation in treatment regimens, and failure to use validated or condition-specific questionnaires. From the available data, bladder preservation appears to result to similar or better general quality of life compared to radical cystectomy with satisfactory urinary and sexual function reported in most series. In general, bladder preservation resulted in more gastrointestinal symptoms than radical cystectomy. This is one of the first reviews on the subject of patient-reported outcomes for bladder preservation in muscle-invasive bladder cancer. Although the data are limited, this review may provide a framework for developing well-designed, prospective comparisons of treatment for this patient cohort.
AbstractList For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus on patients eligible for radical cystectomy, for whom a comparison of patient-reported outcomes is most relevant. Peer-reviewed, English-language manuscripts in MEDLINE and PubMed databases were examined from 1996 through 2014. Subject headings included quality of life, bladder cancer, bladder sparing, bladder preservation, radiation, and radiotherapy. Prospective and retrospective studies of patient-reported outcomes in patients undergoing bladder preservation with radiotherapy for muscle-invasive bladder cancer were included. Two prospective studies and four retrospective studies were identified. Several weaknesses from these studies were identified including small sample sizes, variable time points of assessment, variation in treatment regimens, and failure to use validated or condition-specific questionnaires. From the available data, bladder preservation appears to result to similar or better general quality of life compared to radical cystectomy with satisfactory urinary and sexual function reported in most series. In general, bladder preservation resulted in more gastrointestinal symptoms than radical cystectomy. This is one of the first reviews on the subject of patient-reported outcomes for bladder preservation in muscle-invasive bladder cancer. Although the data are limited, this review may provide a framework for developing well-designed, prospective comparisons of treatment for this patient cohort.
For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus on patients eligible for radical cystectomy, for whom a comparison of patient-reported outcomes is most relevant. Peer-reviewed, English-language manuscripts in MEDLINE and PubMed databases were examined from 1996 through 2014. Subject headings included quality of life, bladder cancer, bladder sparing, bladder preservation, radiation, and radiotherapy. Prospective and retrospective studies of patient-reported outcomes in patients undergoing bladder preservation with radiotherapy for muscle-invasive bladder cancer were included. Two prospective studies and four retrospective studies were identified. Several weaknesses from these studies were identified including small sample sizes, variable time points of assessment, variation in treatment regimens, and failure to use validated or condition-specific questionnaires. From the available data, bladder preservation appears to result to similar or better general quality of life compared to radical cystectomy with satisfactory urinary and sexual function reported in most series. In general, bladder preservation resulted in more gastrointestinal symptoms than radical cystectomy. This is one of the first reviews on the subject of patient-reported outcomes for bladder preservation in muscle-invasive bladder cancer. Although the data are limited, this review may provide a framework for developing well-designed, prospective comparisons of treatment for this patient cohort.For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus on patients eligible for radical cystectomy, for whom a comparison of patient-reported outcomes is most relevant. Peer-reviewed, English-language manuscripts in MEDLINE and PubMed databases were examined from 1996 through 2014. Subject headings included quality of life, bladder cancer, bladder sparing, bladder preservation, radiation, and radiotherapy. Prospective and retrospective studies of patient-reported outcomes in patients undergoing bladder preservation with radiotherapy for muscle-invasive bladder cancer were included. Two prospective studies and four retrospective studies were identified. Several weaknesses from these studies were identified including small sample sizes, variable time points of assessment, variation in treatment regimens, and failure to use validated or condition-specific questionnaires. From the available data, bladder preservation appears to result to similar or better general quality of life compared to radical cystectomy with satisfactory urinary and sexual function reported in most series. In general, bladder preservation resulted in more gastrointestinal symptoms than radical cystectomy. This is one of the first reviews on the subject of patient-reported outcomes for bladder preservation in muscle-invasive bladder cancer. Although the data are limited, this review may provide a framework for developing well-designed, prospective comparisons of treatment for this patient cohort.
ArticleNumber 75
Author Goenka, Anuj
Feuerstein, Michael A.
Author_xml – sequence: 1
  givenname: Michael A.
  surname: Feuerstein
  fullname: Feuerstein, Michael A.
  email: Mfeuerste1@nshs.edu
  organization: Department of Urology, Lenox Hill Hospital, Hofstra-North Shore LIJ School of Medicine
– sequence: 2
  givenname: Anuj
  surname: Goenka
  fullname: Goenka, Anuj
  organization: Department of Radiation Medicine, Lenox Hill Hospital, Hofstra-North Shore LIJ School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26343030$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v2zAMhoWhxfr5A3opdNzFm2jZknPcgq0bEKAfaM6CJNOpCkfKJLlD_v2UJt1hh55IEM9DgHzPyJEPHgm5AvYZGJNfEsCMNxWDtmJtIyv4QE6hLRNRd-3Rrq9lVUsuT8hZSs-M1Yx1zUdyUgvecMbZKRnuJz26vKVhoAs3IL2dsg1rTHQIkX4bdd9jpHPtbSl3Ojv0OdGlL9NVcH71D7mLmDC-FCJ4-sflJ_qgexfyE0a92V6Q40GPCS8P9Zwsf3x_nP-sFrc3v-ZfF5XlTZOrrudc9oZZZmzHcNZ0IICDldL2wuhW8g5aI9pyGEeOiKYfjBFCgzDYGMHPyaf93k0MvydMWa1dsjiO2mOYkgIJrG5BzuqCXh_QyayxV5vo1jpu1dtvCiD3gI0hpYiDsi6_3pejdqMCpnYpqH0KqqSgdikoKCb8Z74tf8-p904qrF9hVM9hir486x3pLz7HmZ0
CitedBy_id crossref_primary_10_1111_iju_13495
crossref_primary_10_1371_journal_pone_0161886
crossref_primary_10_1007_s11136_016_1493_1
crossref_primary_10_1007_s11136_020_02544_z
crossref_primary_10_1111_bju_15864
crossref_primary_10_3233_BLC_210011
crossref_primary_10_3390_molecules21101406
crossref_primary_10_3390_radiation2040025
crossref_primary_10_1155_2016_9174903
crossref_primary_10_15407_exp_oncology_2024_04_351
crossref_primary_10_1016_j_clgc_2018_09_023
crossref_primary_10_1016_j_canrad_2020_04_014
crossref_primary_10_1186_s13014_023_02338_w
crossref_primary_10_1016_j_bbrc_2017_04_009
crossref_primary_10_1136_flgastro_2020_101430
crossref_primary_10_1016_j_ijrobp_2016_08_023
crossref_primary_10_3389_fphar_2021_684915
crossref_primary_10_1177_11772719241297168
crossref_primary_10_1007_s00345_018_2606_y
crossref_primary_10_1038_nrclinonc_2016_79
crossref_primary_10_1016_j_urolonc_2023_07_005
crossref_primary_10_1016_j_clon_2017_01_040
crossref_primary_10_3233_BLC_190233
crossref_primary_10_3892_ijo_2016_3606
Cites_doi 10.1001/jama.2013.879
10.1016/j.urology.2004.02.024
10.1016/j.radonc.2003.05.001
10.1002/(SICI)1097-0142(19960901)78:5<1089::AID-CNCR20>3.0.CO;2-Y
10.1023/A:1025144617752
10.1377/hlthaff.2014.0225
10.1016/S0360-3016(00)00653-2
10.1016/S0167-8140(01)00455-8
10.1200/JCO.2008.19.5776
10.1097/01.ju.0000149080.82697.65
10.1016/j.eururo.2008.07.031
10.1080/02841860802251575
10.1016/S0167-8140(98)00109-1
10.1097/01.ju.0000093721.23249.c3
10.1200/JCO.2012.42.5967
10.1016/j.ijrobp.2009.10.038
10.1200/JCO.2014.58.5521
ContentType Journal Article
Copyright Springer Science+Business Media New York 2015
Copyright_xml – notice: Springer Science+Business Media New York 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s11934-015-0547-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1534-6285
ExternalDocumentID 26343030
10_1007_s11934_015_0547_1
Genre Journal Article
Review
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29F
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5VS
6NX
875
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACZOJ
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEGXH
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
B-.
BA0
BDATZ
BGNMA
C1A
CAG
COF
CS3
CSCUP
CUW
DDRTE
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
I~Z
J-C
JBSCW
JZLTJ
KOV
LLZTM
M4Y
MA-
N9A
NPVJJ
NQJWS
NU0
O9-
O9J
P9S
PF0
PT4
QOR
QOS
R89
R9I
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
Z7U
Z82
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c344t-8d337db0c0bc80e94816131c77cd6ba573815b651523e3eeebdfbb66a16be4b63
IEDL.DBID U2A
ISSN 1527-2737
1534-6285
IngestDate Sun Aug 24 04:05:57 EDT 2025
Mon Jul 21 05:41:35 EDT 2025
Thu Apr 24 22:54:56 EDT 2025
Tue Jul 01 02:08:52 EDT 2025
Fri Feb 21 02:36:38 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Patient-reported outcomes
Radiotherapy
Bladder cancer
Quality of life
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c344t-8d337db0c0bc80e94816131c77cd6ba573815b651523e3eeebdfbb66a16be4b63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 26343030
PQID 1710251792
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1710251792
pubmed_primary_26343030
crossref_citationtrail_10_1007_s11934_015_0547_1
crossref_primary_10_1007_s11934_015_0547_1
springer_journals_10_1007_s11934_015_0547_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-11-01
PublicationDateYYYYMMDD 2015-11-01
PublicationDate_xml – month: 11
  year: 2015
  text: 2015-11-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Current urology reports
PublicationTitleAbbrev Curr Urol Rep
PublicationTitleAlternate Curr Urol Rep
PublicationYear 2015
Publisher Springer US
Publisher_xml – name: Springer US
References Shabsigh, Korets, Vora (CR3) 2009; 55
CR4
Howie, Hirsch, Locklear (CR6) 2014; 33
Caffo, Fellin, Graffer (CR11) 1996; 78
CR5
Calvert, Blazeby, Altman (CR18) 2013; 309
CR9
Porter, Penson (CR2) 2005; 173
Botteman, Pashos, Hauser (CR1) 2003; 12
CR13
Henningsohn, Wijkstrom, Dickman (CR7) 2002; 62
Zietman, Sacco, Skowronski (CR10) 2003; 170
Roeske, Bonta, Mell (CR16) 2003; 69
Herman, Smith, Montie (CR8) 2004; 64
Efstathiou, Bae, Shipley (CR14) 2009; 27
Sondergaard, Hoyer, Petersen (CR17) 2009; 48
Nutting, Convery, Cosgrove (CR15) 2000; 48
Little, Howard (CR12) 1998; 49
J Sondergaard (547_CR17) 2009; 48
JM Herman (547_CR8) 2004; 64
547_CR5
547_CR4
O Caffo (547_CR11) 1996; 78
A Shabsigh (547_CR3) 2009; 55
L Howie (547_CR6) 2014; 33
547_CR13
MF Botteman (547_CR1) 2003; 12
JC Roeske (547_CR16) 2003; 69
M Calvert (547_CR18) 2013; 309
FA Little (547_CR12) 1998; 49
JA Efstathiou (547_CR14) 2009; 27
547_CR9
AL Zietman (547_CR10) 2003; 170
CM Nutting (547_CR15) 2000; 48
L Henningsohn (547_CR7) 2002; 62
MP Porter (547_CR2) 2005; 173
23071244 - J Clin Oncol. 2012 Dec 1;30(34):4249-55
14532773 - J Urol. 2003 Nov;170(5):1772-6
11937249 - Radiother Oncol. 2002 Feb;62(2):215-25
18675501 - Eur Urol. 2009 Jan;55(1):164-74
25366679 - J Clin Oncol. 2014 Dec 1;32(34):3787-8
8780548 - Cancer. 1996 Sep 1;78(5):1089-97
14643959 - Radiother Oncol. 2003 Nov;69(2):201-7
10052881 - Radiother Oncol. 1998 Nov;49(2):157-61
25006149 - Health Aff (Millwood). 2014 Jul;33(7):1220-8
23443445 - JAMA. 2013 Feb 27;309(8):814-22
14516177 - Qual Life Res. 2003 Sep;12(6):675-88
11020560 - Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):649-56
18759144 - Acta Oncol. 2009;48(2):238-44
19636019 - J Clin Oncol. 2009 Sep 1;27(25):4055-61
15245938 - Urology. 2004 Jul;64(1):69-73
15758789 - J Urol. 2005 Apr;173(4):1318-22
References_xml – volume: 309
  start-page: 814
  year: 2013
  ident: CR18
  article-title: Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension
  publication-title: JAMA
  doi: 10.1001/jama.2013.879
– volume: 64
  start-page: 69
  year: 2004
  ident: CR8
  article-title: Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy
  publication-title: Urology
  doi: 10.1016/j.urology.2004.02.024
– volume: 69
  start-page: 201
  year: 2003
  ident: CR16
  article-title: A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2003.05.001
– volume: 78
  start-page: 1089
  year: 1996
  ident: CR11
  article-title: Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. a survey by a self-administered questionnaire
  publication-title: Cancer
  doi: 10.1002/(SICI)1097-0142(19960901)78:5<1089::AID-CNCR20>3.0.CO;2-Y
– volume: 12
  start-page: 675
  year: 2003
  ident: CR1
  article-title: Quality of life aspects of bladder cancer: a review of the literature
  publication-title: Qual Life Res
  doi: 10.1023/A:1025144617752
– ident: CR4
– volume: 33
  start-page: 1220
  year: 2014
  ident: CR6
  article-title: Assessing the value of patient-generated data to comparative effectiveness research
  publication-title: Health Aff (Millwood)
  doi: 10.1377/hlthaff.2014.0225
– volume: 48
  start-page: 649
  year: 2000
  ident: CR15
  article-title: Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/S0360-3016(00)00653-2
– volume: 62
  start-page: 215
  year: 2002
  ident: CR7
  article-title: Distressful symptoms after radical radiotherapy for urinary bladder cancer
  publication-title: Radiother Oncol
  doi: 10.1016/S0167-8140(01)00455-8
– volume: 27
  start-page: 4055
  year: 2009
  ident: CR14
  article-title: Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89–03, 95–06, 97–06, 99–06
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.19.5776
– ident: CR13
– volume: 173
  start-page: 1318
  year: 2005
  ident: CR2
  article-title: Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature
  publication-title: J Urol
  doi: 10.1097/01.ju.0000149080.82697.65
– volume: 55
  start-page: 164
  year: 2009
  ident: CR3
  article-title: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2008.07.031
– ident: CR9
– volume: 48
  start-page: 238
  year: 2009
  ident: CR17
  article-title: The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy
  publication-title: Acta Oncol
  doi: 10.1080/02841860802251575
– volume: 49
  start-page: 157
  year: 1998
  ident: CR12
  article-title: Sexual function following radical radiotherapy for bladder cancer
  publication-title: Radiother Oncol
  doi: 10.1016/S0167-8140(98)00109-1
– ident: CR5
– volume: 170
  start-page: 1772
  year: 2003
  ident: CR10
  article-title: Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors
  publication-title: J Urol
  doi: 10.1097/01.ju.0000093721.23249.c3
– volume: 48
  start-page: 649
  year: 2000
  ident: 547_CR15
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/S0360-3016(00)00653-2
– volume: 309
  start-page: 814
  year: 2013
  ident: 547_CR18
  publication-title: JAMA
  doi: 10.1001/jama.2013.879
– volume: 173
  start-page: 1318
  year: 2005
  ident: 547_CR2
  publication-title: J Urol
  doi: 10.1097/01.ju.0000149080.82697.65
– volume: 48
  start-page: 238
  year: 2009
  ident: 547_CR17
  publication-title: Acta Oncol
  doi: 10.1080/02841860802251575
– volume: 33
  start-page: 1220
  year: 2014
  ident: 547_CR6
  publication-title: Health Aff (Millwood)
  doi: 10.1377/hlthaff.2014.0225
– volume: 49
  start-page: 157
  year: 1998
  ident: 547_CR12
  publication-title: Radiother Oncol
  doi: 10.1016/S0167-8140(98)00109-1
– volume: 55
  start-page: 164
  year: 2009
  ident: 547_CR3
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2008.07.031
– volume: 62
  start-page: 215
  year: 2002
  ident: 547_CR7
  publication-title: Radiother Oncol
  doi: 10.1016/S0167-8140(01)00455-8
– ident: 547_CR5
  doi: 10.1200/JCO.2012.42.5967
– volume: 27
  start-page: 4055
  year: 2009
  ident: 547_CR14
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.19.5776
– volume: 64
  start-page: 69
  year: 2004
  ident: 547_CR8
  publication-title: Urology
  doi: 10.1016/j.urology.2004.02.024
– volume: 12
  start-page: 675
  year: 2003
  ident: 547_CR1
  publication-title: Qual Life Res
  doi: 10.1023/A:1025144617752
– ident: 547_CR4
– ident: 547_CR9
  doi: 10.1016/j.ijrobp.2009.10.038
– ident: 547_CR13
  doi: 10.1200/JCO.2014.58.5521
– volume: 170
  start-page: 1772
  year: 2003
  ident: 547_CR10
  publication-title: J Urol
  doi: 10.1097/01.ju.0000093721.23249.c3
– volume: 69
  start-page: 201
  year: 2003
  ident: 547_CR16
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2003.05.001
– volume: 78
  start-page: 1089
  year: 1996
  ident: 547_CR11
  publication-title: Cancer
  doi: 10.1002/(SICI)1097-0142(19960901)78:5<1089::AID-CNCR20>3.0.CO;2-Y
– reference: 15245938 - Urology. 2004 Jul;64(1):69-73
– reference: 23071244 - J Clin Oncol. 2012 Dec 1;30(34):4249-55
– reference: 25006149 - Health Aff (Millwood). 2014 Jul;33(7):1220-8
– reference: 8780548 - Cancer. 1996 Sep 1;78(5):1089-97
– reference: 11020560 - Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):649-56
– reference: 10052881 - Radiother Oncol. 1998 Nov;49(2):157-61
– reference: 14643959 - Radiother Oncol. 2003 Nov;69(2):201-7
– reference: 18759144 - Acta Oncol. 2009;48(2):238-44
– reference: 11937249 - Radiother Oncol. 2002 Feb;62(2):215-25
– reference: 14516177 - Qual Life Res. 2003 Sep;12(6):675-88
– reference: 18675501 - Eur Urol. 2009 Jan;55(1):164-74
– reference: 19636019 - J Clin Oncol. 2009 Sep 1;27(25):4055-61
– reference: 23443445 - JAMA. 2013 Feb 27;309(8):814-22
– reference: 15758789 - J Urol. 2005 Apr;173(4):1318-22
– reference: 14532773 - J Urol. 2003 Nov;170(5):1772-6
– reference: 25366679 - J Clin Oncol. 2014 Dec 1;32(34):3787-8
SSID ssj0020084
Score 2.1748078
SecondaryResourceType review_article
Snippet For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 75
SubjectTerms Combined Modality Therapy
Cystectomy - methods
Humans
Medicine
Medicine & Public Health
Neoplasm Invasiveness
Nephrology
Quality of Life
Section Editor
Topical Collection on Urothelial Cancer
Treatment Outcome
Urinary Bladder Neoplasms - radiotherapy
Urinary Bladder Neoplasms - therapy
Urology
Urothelial Cancer (A Sagalowsky
Title Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy
URI https://link.springer.com/article/10.1007/s11934-015-0547-1
https://www.ncbi.nlm.nih.gov/pubmed/26343030
https://www.proquest.com/docview/1710251792
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA_iQHwRv60fI4JPSqFt2qR7nGNzqFMRB_OpNF8yGK2s3cP-e3P9GjIVfE8TenfJ_ZK7-x1CV0woSmjcsTWDMGMncGyunNCWMtRE-Vq7EgqcR090OPbvJ8GkquPO6mz3OiRZnNSrYjeDNSBjIrANzGC2ufK0AqCTMkY89rrNLQsY4guSVI9B3QmrQ5k_TfHdGa0hzLXoaOF0Brtop0KLuFuqdw9tqGQfbY2qePgB0iUFxhKnGj9OtcLPi9z8jcqwwaL4dgbHyhz3QLNz_FJSqGa46HX0kZoVmyGQiVE_z2J4m8WvsZxW1VnLQzQe9N96Q7vqnGAL4vu5HUpCmOSOcLgIHQWMLMZtu4IxISmPA2b8dMChC7pHFFFKcak5pzR2KVc-p-QIbSZpok4Q5tqPVWiOATOJcWSko4XHqBMTKiRsfws5tQgjUdGKQ3eLWbQiRAapR0bqEUg9ci103XzyWXJq_DX4stZLZCwfwhlxotJFFrkAjoBhzLPQcamwZjqPEt84Z8dCN7UGo2pzZr-vdfqv0Wdo2wNTKgoTz9FmPl-oC4NQct5Gre7d-0O_XVjmFw3d3Rs
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS8MwFA4yQX0R79ZrBJ-UQtu0Sfc4h2PqNkU22FtobjIYnazbw_69Ob1syFTwPU3oOUnOl3w530HolklNCU3qrmFAM9YjzxXai12lYkN0aIyvIMG526PtQfg8jIZlHndWvXavKMl8p14lu1msAS8mItfCDObaI88msIxw4hoEjeUpCxTic5HUgEHeCauozJ-6-B6M1hDmGjuaB53WHtot0SJuFO7dRxs6PUBb3ZIPP0SmkMBY4InBnZHR-HU-s3-jM2yxKH4Yw7YyxU3w7BS_FRKqGc5rHX1M7IjLJvASo7qexXA3i98TNSqzsxZHaNB67Dfbblk5wZUkDGdurAhhSnjSEzL2NCiy2LDtS8akoiKJmI3TkYAq6AHRRGstlBGC0sSnQoeCkmNUSyepPkVYmDDRsd0GbCc2kJG6kQGjXkKoVLD8HeRVJuSylBWH6hZjvhJEBqtza3UOVue-g-6Wn3wWmhp_Nb6p_MLtzAc6I0n1ZJ5xH8ARKIwFDjopHLbsLqAktMHZc9B95UFeLs7s97HO_tX6Gm23-90O7zz1Xs7RTgDTKk9SvEC12XSuLy1amYmrfHZ-AYQL3mo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED9NRap4YWN8rLAxI_EECiRxYqePXaHjq4AQSPBk4q8JDaWoSR-6v36-JilihUmId8d2fOfzz7673wFscWUYZWnbsxzdjO3Y96TxE0_rxFITWRtoTHDun7HD6-j4Jr6p6pzmdbR77ZIscxqQpSkr9h613XtKfHO4A6MnYs9BDu65689chCUkGjDX-Xl7cjC9cyFf_IQyNeSYhcJrx-ZLnTw_mmbw5oyvdHIE9T7CXT35MvLk9-6okLvqzz-8ju_4u0-wUMFT0in1aRE-mOwzNPuVA34JbMm5MSYDS07vrSHno8INYHLiwC_58YB2bEi6qEpDclFytuZkUlzp18DNZ9oEQz_q92CCj8HkMtX3VTrYeBmuewdX3UOvKtXgKRpFhZdoSrmWvvKlSnyDFDAOJwSKc6WZTGPugEEssex6SA01xkhtpWQsDZg0kWR0BRrZIDNfgEgbpSZxdsd14k5O2rYq5MxPKVMa7U0L_FpKQlU85lhO40E8MTDj-gm3fgLXTwQt2J5-8liSePyv8WYteuG2GvpP0swMRrkIEI0hpVnYgtVSJ6bdhYxGDg34Ldip5Ssqa5C_Ptbam1p_h-bFfk-cHp2drMN8iPoxSYr8Co1iODLfHDoq5Ea1A_4ChQcEHQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quality+of+Life+Outcomes+for+Bladder+Cancer+Patients+Undergoing+Bladder+Preservation+with+Radiotherapy&rft.jtitle=Current+urology+reports&rft.au=Feuerstein%2C+Michael+A&rft.au=Goenka%2C+Anuj&rft.date=2015-11-01&rft.issn=1534-6285&rft.eissn=1534-6285&rft.volume=16&rft.issue=11&rft.spage=75&rft_id=info:doi/10.1007%2Fs11934-015-0547-1&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-2737&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-2737&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-2737&client=summon